Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Current Biology : CB
|
March 21, 2006
DNA replication fidelity: proofreading in trans
Tina M Albertson, Bradley D Preston
Seminars in Cancer Biology
|
October 19, 2010
DNA replication fidelity and cancer
Bradley D Preston, Tina M Albertson, Alan J Herr
Toxicologic Pathology
|
March 2, 2010
Case series: acute tumor lysis syndrome in mutator mice with disseminated lymphoblastic lymphoma
Piper M Treuting, Tina M Albertson, Bradley D Preston
Contemporary Clinical Trials
|
April 26, 2016
A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population
Melanie Quintana, Daniel H Li, Tina M Albertson, et al.
DNA Repair
|
November 10, 2009
Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase
Kiranjit K Dhillon, Julia M Sidorova, Tina M Albertson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice
Tina M Albertson, Masanori Ogawa, James M Bugni, et al.
Lancet (London, England)
|
September 5, 2020
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Current Biology : CB
|
March 21, 2006
DNA replication fidelity: proofreading in trans
Tina M Albertson, Bradley D Preston
Seminars in Cancer Biology
|
October 19, 2010
DNA replication fidelity and cancer
Bradley D Preston, Tina M Albertson, Alan J Herr
Toxicologic Pathology
|
March 2, 2010
Case series: acute tumor lysis syndrome in mutator mice with disseminated lymphoblastic lymphoma
Piper M Treuting, Tina M Albertson, Bradley D Preston
Contemporary Clinical Trials
|
April 26, 2016
A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population
Melanie Quintana, Daniel H Li, Tina M Albertson, et al.
DNA Repair
|
November 10, 2009
Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase
Kiranjit K Dhillon, Julia M Sidorova, Tina M Albertson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice
Tina M Albertson, Masanori Ogawa, James M Bugni, et al.
Lancet (London, England)
|
September 5, 2020
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, et al.
Page
of 1